Oxaliplatin-induced painful neuropathy--flicker of hope or hopeless pain?

Pain. 2009 Aug;144(3):225-226. doi: 10.1016/j.pain.2009.05.004. Epub 2009 May 23.

Authors

Maike Stengel¹, Ralf Baron

Affiliation

¹ Sektion Neurologische Schmerzforschung und - therapie, Klinik für Neurologie, Christian-Albrechts-Universität Kiel, Schittenhelmstr. 10, 24105 Kiel, Germany.

PMID: 19477073
DOI: 10.1016/j.pain.2009.05.004

No abstract available

Publication types

Editorial
Comment

MeSH terms

Antineoplastic Agents / adverse effects*
Early Diagnosis
Ganglia, Spinal / drug effects
Ganglia, Spinal / pathology
Ganglia, Spinal / physiopathology
Humans
Hyperalgesia / chemically induced
Hyperalgesia / complications
Hyperalgesia / physiopathology
Nerve Degeneration / chemically induced
Nerve Degeneration / pathology
Nerve Degeneration / physiopathology
Neuralgia / chemically induced*
Neuralgia / diagnosis*
Neuralgia / prevention & control
Neuroprotective Agents / therapeutic use
Organoplatinum Compounds / adverse effects*
Oxaliplatin
Peripheral Nerves / drug effects
Peripheral Nerves / pathology
Peripheral Nerves / physiopathology
Peripheral Nervous System Diseases / chemically induced*
Peripheral Nervous System Diseases / diagnosis*
Peripheral Nervous System Diseases / prevention & control
Risk Factors

Substances

Antineoplastic Agents
Neuroprotective Agents
Organoplatinum Compounds
Oxaliplatin